"10.1371_journal.pone.0009253","plos one","2010-02-16T00:00:00Z","Guillaume Lucas; Jenny Du; Thomas Romeas; Ouissame Mnie-Filali; Nasser Haddjeri; Graciela Piñeyro; Guy Debonnel","Department of Psychiatry, Centre de Recherche Fernand Seguin, Université de Montréal, Montréal, Québec, Canada; EAC CNRS 3006, ISPB Université de Lyon 1, Faculty of Pharmacy, Lyon, France; Department of Psychiatry, Bâtiment de Recherche et de Formation, Université McGill, Montréal, Québec, Canada","Conceived and designed the experiments: GL. Performed the experiments: GL JD TR OMF NH GP. Analyzed the data: GL NH GP GD. Wrote the paper: GL GD. General supervision of the study: GL GD.","Guillaume Lucas and Guy Debonnel have co-authored a patent in 2006 in partnership with McGill University (Lucas G, Debonnel G, Stimulators of 5-HT4 receptors and uses thereof. World Intellectual Property Organization, International Publication Number WO 2006/029520 A1). The invention describes the therapeutic benefits that can be expected from the association of a 5-HT4 receptor agonist with a conventional antidepressant for the treatment of depression and several related mood disorders. Dr. Guillaume Lucas, as well as Dr. Debonnels heirs, could financially benefit from publication with regards to this patent. Wyeth Ayerst Canada partly funded this study (see Financial Disclosure). This funding does not alter our full adherence to all the PLoS ONE policies on sharing data and materials. Wyeth Ayerst did not take any part in the conception, writing and deposit application of the aforementioned patent, and does not constitute one of the parties involved in the process. This company cannot expect any financial gain related to this patent.","2010","02","Guillaume Lucas","GL",7,TRUE,1,6,4,2,TRUE,TRUE,FALSE,0,NA,FALSE
